CATO SMS is committed to providing the highest quality services for you. Our global biometrics group is a dedicated, experienced team of biostatistics, statistical programming, and data management professionals devoted to delivering individualized, adaptable, and dedicated services to support all of your data and analytical needs. We strive to provide you with the best solutions and, in September 2020, we acquired Array Biostatistics to expand our biostatistical consulting, analysis, and programming capabilities.
Biostatistics and Statistical Programming
With years of expertise designing and implementing Phase I-IV clinical trials, integrated analyses, and patient registries — along with a dynamic approach and clear communication across all functional areas — we ensure your clinical studies are conducted with efficiency, quality, and scientific integrity. Our experienced team effectively anticipates risks, prevents delays, avoids extra costs, allocates resources appropriately, and develops realistic timelines.
All deliverables are flexible and customized toward meeting your needs. We can act as your primary statistical team to design and execute your clinical study or fill in to provide as-needed support to your existing statistical team — and everything in between.
Data Management
From database design and setup through cleaning and reporting to database lock, CATO SMS delivers timely and quality data by using the latest technologies, robust processes, and regulatory-compliant data management tools. We apply standardized and established processes from electronic case report form (eCRF) design to the delivery of final datasets. We are experts in the development of therapeutic area-specific eCRFs and can manage studies efficiently in any therapeutic indication.
CATO SMS has provided data management services to the biopharmaceutical industry for over 20 years. Our senior clinical data managers and clinical programmers have an average of more than 10 years of industry experience and broad expertise covering all phases (I-IV) extending to registries and observational studies in numerous therapeutic areas. We have experience with a range of electronic data capture (EDC) systems.
Sandy Ferber, MS
President, Biometrics
+MORE
Lori Davis, PhD, MSc
Senior Director, Biostatistical Consulting
+MORE
Analyn Animo, BSc
Global Head of Data Management
+MORE
– CLOSE
Sandy Ferber, MS
President, Biometrics
As President of Biometrics at CATO SMS, Sandy Ferber is responsible for global data management, biostatistics, and statistical programming. Ms. Ferber provides clients solutions for complex study designs in standard and innovative regulatory paths. She has served as the lead statistician on Phase I-IV clinical trials, patient registries, and multiple drug submissions that ultimately led to approvals.
Before her appointment as President of Biometrics, Ms. Ferber served as the founder and CEO of Array Biostatistics, where she led a full-service biostatistical and statistical programming CRO. She developed strategies for clinical development programs and individual trials, performed analyses, and provided statistical leadership in collaboration with the FDA and European regulatory authorities. Before founding Array Biostatistics, Ms. Ferber began her career as a biostatistician with INC Research, where she progressed to the role of principal biostatistician.
Ms. Ferber holds an MS in Epidemiology and Biostatistics from Case Western Reserve University in Ohio.
– CLOSE
– CLOSE
Lori Davis, PhD, MSc
Senior Director, Biostatistical Consulting
As Senior Director of Biostatistical Consulting at CATO SMS, Lori Davis is responsible for the biostatistical methodology and development of scientific strategy for handling complex statistically focused challenges within clinical trial design, execution, and reporting. She has developed effective leadership in directing biostatistical strategies across an array of therapeutic areas and indications. Dr. Davis also serves as the primary contact for statistical activities and consultation, and attends client, scientific, and regulatory meetings.
Before joining CATO SMS, Dr. Davis held leadership roles including president of Davis Biostatistics, director of biostatistics for ProNai Therapeutics, and principal research statistician for inVentiv Health Clinical and Pharmanet. Throughout her career, she has consulted for pharmaceuticals, CROs, and other organizations.
Dr. Davis holds a PhD in Biostatistics from the University of Toronto and an MSc from Queens University. Dr. Davis has co-authored over 20 publications covering various topics including dermatology, oncology, psychopharmacology, analgesia, and more.
– CLOSE
– CLOSE
Analyn Animo, BSc
Global Head of Data Management
As Global Head of Data Management at CATO SMS, Analyn Animo oversees the quality, planning, and execution of all data management activities. Her therapeutic area experience includes rare diseases, orphan drugs, cell and gene therapy, gastrointestinal, hepatology, analgesia, and central nervous system. Before her current position, she served as director of biometrics at CATO SMS and director of data management at SMS Oncology (now part of CATO SMS), successfully building and developing the data management department.
Before joining CATO SMS, Ms. Animo served in various clinical data management roles including senior manager of data management at INC Research and manager and head of clinical data at Kendle International. Ms. Animo has contributed to over 20 clinical trials in oncology ranging from Phase I-IV.
Ms. Animo earned her BSc in Pharmacy at the University of Immaculate Conception in the Philippines and subsequently became a registered pharmacist.
– CLOSE
